Jones Ventures (JONE) Director Shlomo Cohen Receives 100,000 Class B Shares

What Happened

• Shlomo Cohen, a director of Jones Ventures INTL Acquisition1 Corp (JONE), was assigned 100,000 Class B ordinary shares on July 13, 2026. The Form 4 reports a per-share price of $0.00 (acquisition) and lists $300 under the derivative security amount.
• This was not an open‑market purchase or sale but an assignment from the Sponsor related to Mr. Cohen’s appointment to the board (transaction code J = other acquisition/disposition). It represents a non-cash grant/assignment rather than a market trade.

Key Details

• Transaction date: July 13, 2026; Form 4 filed July 17, 2026 (filed late relative to the typical 2‑business‑day Form 4 deadline).
• Transaction reported as: 100,000 Class B ordinary shares acquired @ $0.00; derivative amount reported as $300.
• Shares owned after transaction: not specified in the information provided in this summary (see filing for full beneficial ownership table).
• Footnotes:
  • F1: Class B shares convert one-for-one into Class A ordinary shares at the time of the issuer’s initial business combination (subject to anti-dilution adjustments) and may be forfeitable based on Mr. Cohen’s board service.
  • F2: The 100,000 Class B shares were assigned by Jones Ventures INTL Acquisition1 Sponsor, LLC per a securities purchase agreement dated July 13, 2026, in connection with Cohen’s board appointment.
• Timeliness: The Form 4 was filed four days after the reported transaction date; late filing can draw regulatory attention and potential reporting penalties.

Context

• These Class B shares are a derivative/convertible class tied to the SPAC’s (issuer’s) future business combination and are commonly used for sponsor compensation or director incentives; they are not a direct market signal of insider buying or selling.
• Because the award is tied to board service and subject to forfeiture, it should be viewed as compensation/appointment-related rather than an independent investment decision by the insider.